| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/25/2012 | EP1412379B1 Vaccine |
| 01/25/2012 | EP1355918B9 Recombinant protective protein from $i(streptococcus pneumoniae) |
| 01/25/2012 | EP0791055B1 Method for producing biologicals in protein-free culture |
| 01/25/2012 | CN1982330B Methods for preparing purified lipopeptides |
| 01/25/2012 | CN1374870B Treatment of intermediate-and high-grade non-Hodgkins lymphoma with anti-CD20 antibody |
| 01/25/2012 | CN102333872A Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast pichia pastoris |
| 01/25/2012 | CN102333791A Generation, expression and characterization of the humanized k33n monoclonal antibody |
| 01/25/2012 | CN102333788A Modification of factor viii |
| 01/25/2012 | CN102332532A Halophile photosensitive protein-titanium dioxide nanotube composite and preparation method thereof |
| 01/25/2012 | CN102329847A Method for efficiently expressing recombinant protein |
| 01/25/2012 | CN102329846A Pollution-free production method for producing soybean and silkworm chrysalis composite oligopeptides by adopting composite enzyme hydrolysis method |
| 01/25/2012 | CN102329845A Preparation method of hypotensive peptide of lactalbumin |
| 01/25/2012 | CN102329844A Microbial fermentation enzymolysis method for extracting grease and protein of soybean |
| 01/25/2012 | CN102329843A Enzyme method for preparing gelatin |
| 01/25/2012 | CN102329842A Lamb placenta polypeptide and preparation method thereof |
| 01/25/2012 | CN102329841A Lamb placenta protein and preparation method thereof |
| 01/25/2012 | CN102329840A Preparation method of recombinant protein A |
| 01/25/2012 | CN102329827A Sheep placenta amino acid and low molecular weight polypeptide, and preparation method for sheep placenta amino acid and low molecular weight polypeptide |
| 01/25/2012 | CN102329825A Microbial fermentation method for simultaneously extracting soybean oil and soybean protein |
| 01/25/2012 | CN101717805B Method for preparing wheat protein source opioid peptide by enzymolysis of wheat protein |
| 01/24/2012 | US8101724 High-affinity human antibodies to human protease-activated receptor-2 |
| 01/24/2012 | US8101723 Monoclonal antibodies to fibroblast growth factor receptor 2 |
| 01/24/2012 | US8101722 Bispecific binding molecule which interacts with CD3 complex which reduces immune response and decreases incidence of host vs graft diseases |
| 01/24/2012 | US8101721 Antibodies blocking fibroblast growth factor receptor activation and methods of use thereof |
| 01/24/2012 | US8101720 Immunoglobulin insertions, deletions and substitutions |
| 01/24/2012 | US8101716 Human interferon-beta mutein |
| 01/24/2012 | US8101573 α-conotoxin MII analogs |
| 01/24/2012 | US8101563 Proteases from gram-positive organisms |
| 01/24/2012 | US8101553 Antibody library |
| 01/24/2012 | US8101396 Minicells displaying antibodies or derivatives thereof and comprising biologically active compounds |
| 01/24/2012 | US8101393 Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them |
| 01/24/2012 | US8101388 Method and structure for extracting molecular species |
| 01/24/2012 | US8101382 Modified vitamin K-dependent polypeptides |
| 01/24/2012 | US8101381 Human cytokine receptor |
| 01/24/2012 | US8101380 Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs |
| 01/24/2012 | US8101379 Preparation of low bleeding anticoagulant fusion protein and its use |
| 01/24/2012 | US8101378 Dual expression vector system and screening methods |
| 01/24/2012 | US8101377 Protein hydrolysates and method of making |
| 01/24/2012 | US8101365 Anti-EphB4 antibodies and methods using same |
| 01/24/2012 | US8101347 Method and compositions for immunization with the Pseudomonas V antigen |
| 01/24/2012 | US8101185 Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylation |
| 01/24/2012 | US8101182 Methods and compositions for treating allergic diseases |
| 01/24/2012 | US8101181 Antibodies that immunospecifically bind to B lymphocyte stimulator protein |
| 01/24/2012 | US8101177 Anti-VEGF antibodies |
| 01/24/2012 | US8100169 Spray nozzle apparatus and method of use |
| 01/24/2012 | CA2508763C Human antibody producing mouse and method for producing human antibody using the same |
| 01/24/2012 | CA2460206C Method for production of recombinant proteins in eukaryote cells |
| 01/24/2012 | CA2439428C Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies |
| 01/24/2012 | CA2438935C Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides |
| 01/24/2012 | CA2436754C Production of a monoclonal antibody by a transgenic avian |
| 01/24/2012 | CA2378802C Inactivated vaccine against feline calicivirus disease |
| 01/24/2012 | CA2295691C Methods and compositions for impairing multiplication of hiv-1 |
| 01/24/2012 | CA2274987C Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily |
| 01/24/2012 | CA2269204C Anti-erbb2 antibodies |
| 01/19/2012 | WO2012008595A1 Method for producing anti-lr11 antibody and standard for immunoassay |
| 01/19/2012 | WO2012008584A1 Method for creating antibodies, and antibodies |
| 01/19/2012 | WO2012008397A1 Anti-epha2 antibody and use thereof |
| 01/19/2012 | WO2012007965A1 Enzyme for the production of optically pure 3 - quinuclidinol |
| 01/19/2012 | WO2011143624A3 Humanized and chimeric monoclonal antibodies to cd47 |
| 01/19/2012 | WO2011108809A9 Protease with improved conservation stability, and preparation method thereof |
| 01/19/2012 | WO2011086589A9 Process for the preparation of a biomass comprising plantaricin and uses thereof in medical field |
| 01/19/2012 | US20120017336 Transgenic aloe plants for production of proteins and related methods |
| 01/19/2012 | US20120016340 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 01/19/2012 | US20120016112 Processing of macronutrients |
| 01/19/2012 | US20120016106 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8 associated disorders |
| 01/19/2012 | US20120016008 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN RIBOSOMAL PROTEIN L26 (RIBO26) |
| 01/19/2012 | US20120015890 Use of Soluble Forms of CD83 and Nucleic Acids Encoding them for the Treatment or Prevention of Diseases |
| 01/19/2012 | US20120015840 Methods for generation of rna and (poly)peptide libraries and their use |
| 01/19/2012 | US20120015820 Methods and compositions for polypeptide engineering |
| 01/19/2012 | US20120015438 Mammallian cell culture process for protein production |
| 01/19/2012 | US20120015403 Production and purification of il-29 |
| 01/19/2012 | US20120015402 Method of Proliferating Plasma Cells |
| 01/19/2012 | US20120015401 Plasmodium falciparum antigens and methods of use |
| 01/19/2012 | US20120015400 HCL-K1 Polypeptide Which Offers Collectin Activity |
| 01/19/2012 | US20120015024 Methods for treating tweak-related conditions |
| 01/19/2012 | US20120014996 Method of diagnosing bladder cancer |
| 01/19/2012 | US20120014961 Antibodies that inhibit tslp activity |
| 01/19/2012 | US20120014960 Composition Comprising Antibodies to LINGO or Fragments Thereof |
| 01/19/2012 | US20120014957 Dual variable domain immunoglobulins and uses thereof |
| 01/19/2012 | CA2803322A1 Fermented soya based mixture comprising isoflavones-aglycones, equol and lunasin, process for the preparation thereof and related uses in food, medical and cosmetic fields |
| 01/18/2012 | EP2407548A1 Molecules with reduced half-lives, compositions and uses thereof |
| 01/18/2012 | EP2406399A1 Mirac proteins |
| 01/18/2012 | EP2406388A1 Ox40/trail fusion proteins |
| 01/18/2012 | EP2406387A1 Infectious disease cellular immunotherapy |
| 01/18/2012 | EP2406386A1 Method for improving the yield of a polypeptide |
| 01/18/2012 | EP2406372A1 Pregastric esterase and derivatives thereof |
| 01/18/2012 | EP2406285A1 Generation, expression and characterization of the humanized k33n monoclonal antibody |
| 01/18/2012 | EP2406276A1 Methods of renaturation of recombinant proteins |
| 01/18/2012 | EP2271665B1 Highly bridged peptides from actinomadura namibiensis |
| 01/18/2012 | EP1851305B1 Production of a polypeptide in a serum-free cell culture liquid containing plant protein hydrolysate |
| 01/18/2012 | EP1836298B1 COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF |
| 01/18/2012 | EP1808446B1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| 01/18/2012 | EP1743940B1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide |
| 01/18/2012 | EP1704234B1 Production of glucagon like peptide 2 and analogs |
| 01/18/2012 | EP1457482B1 Stable isotope-labeled amino acid, method of integrating the same into target protein, method of NMR structural analysis of protein |
| 01/18/2012 | EP1456385B1 Growth hormone fusion protein |
| 01/18/2012 | EP1456366B1 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease |
| 01/18/2012 | EP1053256B9 Antibodies to death receptor 4 (dr4) and uses thereof |
| 01/18/2012 | CN102325882A Protein substance having triple helix structure and manufacturing method therefor |
| 01/18/2012 | CN102325881A Expression vector for producing protein derived from foreign gene in large quantity using animal cells, and use thereof |